Acta Diabetologica

Acta Diabetologica

糖尿病学法

  • 3区 中科院分区
  • Q2 JCR分区

期刊简介

《Acta Diabetologica》是由Springer Milan出版社于1964年创办的英文国际期刊(ISSN: 0940-5429,E-ISSN: 1432-5233),该期刊长期致力于内分泌学与代谢领域的创新研究,主要研究方向为医学-内分泌学与代谢。作为SCIE收录期刊(JCR分区 Q2,中科院 3区),本刊采用OA未开放获取模式(OA占比0.1300...%),以发表内分泌学与代谢领域等方向的原创性研究为核心(研究类文章占比89.94%%)。凭借严格的同行评审与高效编辑流程,期刊年载文量精选控制在169篇,确保学术质量与前沿性。成果覆盖Web of Science、Scopus等国际权威数据库,为学者提供推动医学领域高水平交流平台。

投稿咨询

投稿提示

Acta Diabetologica审稿周期约为 约2月 。该刊近年未被列入国际预警名单,年发文量约169篇,录用竞争适中,主题需确保紧密契合医学前沿。投稿策略提示:避开学术会议旺季投稿以缩短周期,语言建议专业润色提升可读性。

  • 医学 大类学科
  • English 出版语言
  • 是否预警
  • SCIE 期刊收录
  • 169 发文量

中科院分区

中科院 SCI 期刊分区 2023年12月升级版

Top期刊 综述期刊 大类学科 小类学科
医学
3区
ENDOCRINOLOGY & METABOLISM 内分泌学与代谢
3区

中科院 SCI 期刊分区 2022年12月升级版

Top期刊 综述期刊 大类学科 小类学科
医学
3区
ENDOCRINOLOGY & METABOLISM 内分泌学与代谢
4区

JCR分区

按JIF指标学科分区 收录子集 分区 排名 百分位
学科:ENDOCRINOLOGY & METABOLISM SCIE Q2 85 / 186

54.6%

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:ENDOCRINOLOGY & METABOLISM SCIE Q2 66 / 186

64.78%

CiteScore

CiteScore SJR SNIP CiteScore 排名
CiteScore:7.3 SJR:0.98 SNIP:0.943
学科类别 分区 排名 百分位
大类:Medicine 小类:Internal Medicine Q1 31 / 167

81%

大类:Medicine 小类:Endocrinology, Diabetes and Metabolism Q1 61 / 244

75%

大类:Medicine 小类:Endocrinology Q2 40 / 128

69%

期刊发文

  • gamma-aminobutyric acid modulates alpha-cell hyperplasia but not beta-cell regeneration induced by glucagon receptor antagonism in type 1 diabetic mice

    Author: Gu, Liangbiao; Cui, Xiaona; Lin, Xiafang; Yang, Jin; Wei, Rui; Hong, Tianpei; Yang, Kun

    Journal: ACTA DIABETOLOGICA. 2023; Vol. 60, Issue 1, pp. 19-28. DOI: 10.1007/s00592-022-01970-4

  • Circ ASAP2 decreased inflammation and ferroptosis in diabetic nephropathy through SOX2/SLC7A11 by miR-770-5p

    Author: Li, Qin; Meng, Xiangjian; Hua, Qiang

    Journal: ACTA DIABETOLOGICA. 2023; Vol. 60, Issue 1, pp. 29-42. DOI: 10.1007/s00592-022-01961-5

  • Development and validation of a model that predicts the risk of diabetic retinopathy in type 2 diabetes mellitus patients

    Author: Yang, Jing; Jiang, Sheng

    Journal: ACTA DIABETOLOGICA. 2023; Vol. 60, Issue 1, pp. 43-51. DOI: 10.1007/s00592-022-01973-1

  • Metabolic-associated fatty liver disease increases the risk of end-stage renal disease in patients with biopsy-confirmed diabetic nephropathy: a propensity-matched cohort study

    Author: Zou, Yutong; Zhao, Lijun; Zhang, Junlin; Wang, Yiting; Wu, Yucheng; Ren, Honghong; Wang, Tingli; Zhao, Yuancheng; Xu, Huan; Li, Lin; Tong, Nanwei; Liu, Fang

    Journal: ACTA DIABETOLOGICA. 2023; Vol. 60, Issue 2, pp. 225-233. DOI: 10.1007/s00592-022-01978-w

  • Effects of sodium-glucose co-transporter-2 inhibitors on kidney, cardiovascular, and safety outcomes in patients with advanced chronic kidney disease: a systematic review and meta-analysis of randomized controlled trials

    Author: Cao, Haiyan; Rao, Xiaosheng; Jia, Junya; Yan, Tiekun; Li, Dong

    Journal: ACTA DIABETOLOGICA. 2023; Vol. 60, Issue 3, pp. 325-335. DOI: 10.1007/s00592-022-01989-7

  • Prognostic nutritional index as a risk factor for diabetic kidney disease and mortality in patients with type 2 diabetes mellitus

    Author: Zhang, Junlin; Chen, Yao; Zou, Liang; Gong, Rong

    Journal: ACTA DIABETOLOGICA. 2023; Vol. 60, Issue 2, pp. 235-245. DOI: 10.1007/s00592-022-01985-x

  • Salivary telomere length and the risks of prediabetes and diabetes among middle-aged and older adults: findings from the Health and Retirement Study

    Author: Yu, Hong-jie; Ho, Mandy; Chau, Pui Hing; Geng, Leiluo; Fong, Daniel Yee Tak

    Journal: ACTA DIABETOLOGICA. 2023; Vol. 60, Issue 2, pp. 273-283. DOI: 10.1007/s00592-022-02004-9

  • Single nucleotide polymorphisms in the GFR-related gene and the SNP-SNP interactions on the risk of diabetic kidney disease in Chinese Han population

    Author: Liu, Yanxiu; Chen, Yan; Yang, Qiwei; Shen, Dihan; Du, Zhenwu; Zhang, Guizhen

    Journal: ACTA DIABETOLOGICA. 2023; Vol. 60, Issue 1, pp. 115-125. DOI: 10.1007/s00592-022-01988-8